Long non-coding RNA: An immune cells perspective.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Apr 2021
Historique:
received: 10 11 2020
revised: 14 01 2021
accepted: 24 01 2021
pubmed: 7 2 2021
medline: 18 3 2021
entrez: 6 2 2021
Statut: ppublish

Résumé

Long non-coding RNAs (lncRNAs) were considered as accumulated genetic waste until they were found to be gene expression regulators by highly sensitive modern genomics platforms. It is a huge class of non-coding transcripts with an arbitrary length of >200 nucleotides, which has gained much attention in the past few years. Increasing evidence from several experimental studies unraveled the expression of lncRNA linked to immune response and disease progression. However, only a small number of lncRNAs have robust evidence of their function. Differential expression of lncRNAs in different immune cells is also evident. In this review, we focused on how lncRNAs expression assist in shaping immune cells (Macrophages, Dendritic cells, NK cells, T cells, B cells, eosinophils, neutrophils, and microglial cells) function and their response to the diseased conditions. Emerging evidence revealed lncRNAs may serve as key regulators in the innate and adaptive immune response system. So, the molecular mechanism insight into the function of lncRNAs in immune response may contribute to the development of potential therapeutic targets for various disease treatments. Therefore, it is imperative to explore the expression of lncRNAs and understand its relevance associated with the immune system.

Identifiants

pubmed: 33548285
pii: S0024-3205(21)00137-5
doi: 10.1016/j.lfs.2021.119152
pii:
doi:

Substances chimiques

Inflammation Mediators 0
RNA, Long Noncoding 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

119152

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Salman Khan (S)

Department of Biotechnology, Jamia Millia Islamia, New Delhi, India.

Mohammad Masood (M)

Department of Biotechnology, Jamia Millia Islamia, New Delhi, India.

Harshita Gaur (H)

Department of Life Sciences, University of Glasgow, United Kingdom.

Shaniya Ahmad (S)

Department of Biotechnology, Jamia Millia Islamia, New Delhi, India. Electronic address: shaniya169053@st.jmi.ac.in.

Mansoor Ali Syed (MA)

Department of Biotechnology, Jamia Millia Islamia, New Delhi, India. Electronic address: smansoor@jmi.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH